CARDIFF ONCOLOGY, INC. (CRDF) Gross profit 2016–2019
CARDIFF ONCOLOGY, INC. (CRDF) annual gross profit history from SEC filings — each fiscal year as reported.
$244,632FY2019 · since FY2016: -$1.3M → $244,632
| Fiscal year | Value | YoY |
|---|---|---|
| FY2019 | $244,632 | +211.6% |
| FY2018 | -$219,132 | +83.2% |
| FY2017 | -$1.3M | +3.2% |
| FY2016 | -$1.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CRDF financial trends
CRDF RevenueCRDF Net incomeCRDF Net marginCRDF Gross marginCRDF Operating incomeCRDF Operating marginCRDF Operating cash flowCRDF Free cash flowCRDF Capital expendituresCRDF Return on equityCRDF Stock buybacksCRDF Dividends paidCRDF Total assetsCRDF Total liabilitiesCRDF Shareholders’ equityCRDF overview →